跳至主要内容
临床试验/NCT02183675
NCT02183675已完成1 期

Pharmacokinetics of Multiple Oral Doses of Telmisartan 80 mg/Amlodipine 5 mg/Hydrochlorothiazide 12.5 mg Fixed-dose Combination Tablet, Telmisartan 80 mg/Hydrochlorothiazide 12.5 mg Fixed-dose Combination Tablet and Telmisartan 80 mg/Amlodipine 5 mg Fixed-dose Combination Tablet at Steady State in Healthy Male Subjects: an Open-label, Randomised, Multiple-dose, Three Treatment, Three-period, Six-sequence Crossover Study

Boehringer Ingelheim1 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2014年7月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
36
试验地点
1
主要终点
Maximum Measured Concentration (Cmax) at Steady State for Amlodipine

研究概览

简要总结

To assess drug drug interaction through pharmacokinetics investigation at steady state of Telmisartan, Amlodipine, and Hydrochlorothiazide (HCTZ) given as three different formulations in healthy Japanese male subjects

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

T/A/H

Experimental

Telmisartan/Amlodipine/HCTZ fixed-dose combination

干预措施: Telmisartan/Amlodipine/HCTZ (Drug)

T/A

Active Comparator

Telmisartan/Amlodipine fixed-dose combination

干预措施: Telmisartan/Amlodipine (Drug)

T/H

Active Comparator

Telmisartan/HCTZ fixed-dose combination

干预措施: Telmisartan/HCTZ (Drug)

结局指标

主要结局

Maximum Measured Concentration (Cmax) at Steady State for Amlodipine

时间窗: 15 minutes (min) before drug administration and 15min, 30min, 45min, 1 hour (h), 1h 30min, 2h, 2h 30min, 3h, 4h, 6h, 8h, 12h, 24h, 32h, 48h, 72h, 96h, 120h and 144h after 10 days drug administration

Maximum measured concentration (Cmax) of amlodipine in plasma at steady state over the dosing interval tau

Maximum Measured Concentration (Cmax) at Steady State for Telmisartan

时间窗: 15 minutes (min) before drug administration and 15min, 30min, 45min, 1 hour (h), 1h 30min, 2h, 2h 30min, 3h, 4h, 6h, 8h, 12h, 24h, 32h, 48h and 72h after 10 days drug administration

Maximum measured concentration (Cmax) of telmisartan in plasma at steady state over the dosing interval tau

Area Under the Plasma Concentration Curve at Steady State for Telmisartan

时间窗: 15 minutes (min) before drug administration and 15min, 30min, 45min, 1 hour (h), 1h 30min, 2h, 2h 30min, 3h, 4h, 6h, 8h, 12h, 24h, 32h, 48h and 72h after 10 days drug administration

Area under the plasma concentration curve (AUC) of telmisartan in plasma at steady state over the dosing interval tau

Maximum Measured Concentration (Cmax) at Steady State for HCTZ

时间窗: 15 minutes (min) before drug administration and 15min, 30min, 45min, 1 hour (h), 1h 30min, 2h, 2h 30min, 3h, 4h, 6h, 8h, 12h, 24h, 32h and 48h after 10 days drug administration

Maximum measured concentration (Cmax) of HCTZ in plasma at steady state over the dosing interval tau

Area Under the Plasma Concentration Curve at Steady State for Amlodipine

时间窗: 15 minutes (min) before drug administration and 15min, 30min, 45min, 1 hour (h), 1h 30min, 2h, 2h 30min, 3h, 4h, 6h, 8h, 12h, 24h, 32h, 48h, 72h, 96h, 120h and 144h after 10 days drug administration

Area under the plasma concentration curve (AUC) of amlodipine in plasma at steady state over the dosing interval tau

Area Under the Plasma Concentration Curve at Steady State for HCTZ

时间窗: 15 minutes (min) before drug administration and 15min, 30min, 45min, 1 hour (h), 1h 30min, 2h, 2h 30min, 3h, 4h, 6h, 8h, 12h, 24h, 32h and 48h after 10 days drug administration

Area under the plasma concentration curve (AUC) of HCTZ in plasma at steady state over the dosing interval tau

次要结局

  • Amount of HCTZ Excreted in Urine at Steady State From 0 to 24 Hours(0-6 hours (h), 6-12h and 12-24h after drug administration on day 10)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验